Maria Mavris

2.0k total citations · 1 hit paper
22 papers, 1.5k citations indexed

About

Maria Mavris is a scholar working on Endocrinology, Genetics and Infectious Diseases. According to data from OpenAlex, Maria Mavris has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, 8 papers in Genetics and 5 papers in Infectious Diseases. Recurrent topics in Maria Mavris's work include Escherichia coli research studies (9 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Bacterial Genetics and Biotechnology (4 papers). Maria Mavris is often cited by papers focused on Escherichia coli research studies (9 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Bacterial Genetics and Biotechnology (4 papers). Maria Mavris collaborates with scholars based in France, Netherlands and Australia. Maria Mavris's co-authors include Philippe Sansonetti, Claude Parsot, Régis Tournebize, Anne‐Laure Page, Paul A. Manning, Renato Morona, Dana J. Philpott, George R. Stark, Peter S. DiStefano and John Bertin and has published in prestigious journals such as Nature Reviews Drug Discovery, Biochemical and Biophysical Research Communications and Journal of Bacteriology.

In The Last Decade

Maria Mavris

22 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CARD4/Nod1 mediates NF‐κB and JNK activation by invasive Shigella flexneri

2001 503 citations Stephen E. Girardin, Régis Tournebize et al. EMBO Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Mavris France	17	546	406	405	387	325	22	1.5k
Deborah H. Schmiel United States	15	265 0.5×	280 0.7×	252 0.6×	404 1.0×	125 0.4×	20	1.4k
Bronwyn M. Gunn United States	26	231 0.4×	222 0.5×	466 1.2×	956 2.5×	1.1k 3.4×	57	2.6k
Nathalie Mielcarek France	23	200 0.4×	133 0.3×	270 0.7×	230 0.6×	372 1.1×	44	1.6k
Joshua Tobias Sweden	23	646 1.2×	142 0.3×	297 0.7×	289 0.7×	604 1.9×	53	1.4k
Jiang Gu China	22	241 0.4×	40 0.1×	220 0.5×	451 1.2×	411 1.3×	53	1.3k
O Barrera United States	16	170 0.3×	218 0.5×	242 0.6×	449 1.2×	191 0.6×	18	1.6k
Eric R. Jensen United States	19	79 0.1×	124 0.3×	1.4k 3.4×	695 1.8×	349 1.1×	31	2.4k
Nikolaus Ackermann Germany	17	171 0.3×	189 0.5×	59 0.1×	315 0.8×	362 1.1×	29	905
Francesco Berlanda Scorza Italy	14	184 0.3×	89 0.2×	217 0.5×	479 1.2×	327 1.0×	42	1.2k
J B Robbins United States	20	505 0.9×	111 0.3×	391 1.0×	447 1.2×	452 1.4×	31	2.0k

Countries citing papers authored by Maria Mavris

Since Specialization

Citations

This map shows the geographic impact of Maria Mavris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Mavris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Mavris more than expected).

Fields of papers citing papers by Maria Mavris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Mavris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Mavris. The network helps show where Maria Mavris may publish in the future.

Co-authorship network of co-authors of Maria Mavris

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Mavris. A scholar is included among the top collaborators of Maria Mavris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Mavris. Maria Mavris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bere, Nathalie, et al.. (2022). The Added Value of Patient Engagement in Early Dialogue at EMA: Scientific Advice as a Case Study. Frontiers in Medicine. 8. 811855–811855. 25 indexed citations

Mavris, Maria, et al.. (2019). Engaging patients in medicines regulation: a tale of two agencies. Nature Reviews Drug Discovery. 18(12). 885–886. 16 indexed citations

Hofer, Matthias P., Maria Mavris, Franz Koenig, et al.. (2017). Marketing authorisation of orphan medicines in Europe from 2000 to 2013. Drug Discovery Today. 23(2). 424–433. 24 indexed citations

Postmus, Douwe, Nathalie Bere, Gert van Valkenhoef, et al.. (2017). Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma. The Oncologist. 23(1). 44–51. 43 indexed citations

Postmus, Douwe, Maria Mavris, Tomas Salmonson, et al.. (2015). Incorporating patient preferences into drug development and regulatory decision making: Results from a quantitative pilot study with cancer patients, carers, and regulators. Clinical Pharmacology & Therapeutics. 99(5). 548–554. 59 indexed citations

Mavris, Maria, et al.. (2013). Animal models for metabolic, neuromuscular and ophthalmological rare diseases. Nature Reviews Drug Discovery. 12(4). 287–305. 29 indexed citations

Mavris, Maria & Yann Le Cam. (2012). Involvement of Patient Organisations in Research and Development of Orphan Drugs for Rare Diseases in Europe. Molecular Syndromology. 3(5). 237–243. 48 indexed citations

Vayssier‐Taussat, Muriel, Danielle Le Rhun, Francis Biville, et al.. (2010). The Trw Type IV Secretion System of Bartonella Mediates Host-Specific Adhesion to Erythrocytes. PLoS Pathogens. 6(6). e1000946–e1000946. 94 indexed citations

Mavris, Maria, et al.. (2010). EURORDIS Summer School for patient advocates in clinical trials and drug development. Orphanet Journal of Rare Diseases. 5(S1). 1 indexed citations

10.

Halos, Lénaïg, Maria Mavris, Gwenaël Vourc’h, et al.. (2006). Broad-range PCR-TTGE for the first-line detection of bacterial pathogen DNA in ticks. Veterinary Research. 37(2). 245–253. 16 indexed citations

11.

Parsot, Claude, et al.. (2005). A secreted anti‐activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri. Molecular Microbiology. 56(6). 1627–1635. 97 indexed citations

12.

Mavris, Maria, Henri Saenz, Martine Monteil, et al.. (2005). Characterization of Genes Involved in Long‐Term Bacteremia in Mice by Bartonella birtlesii. Annals of the New York Academy of Sciences. 1063(1). 312–314. 10 indexed citations

13.

Mavris, Maria, et al.. (2005). Topological analysis of GtrA and GtrB proteins encoded by the serotype-converting cassette of Shigella flexneri. Biochemical and Biophysical Research Communications. 328(4). 1252–1260. 30 indexed citations

14.

Gall, Tony Le, Maria Mavris, Maria Celeste Martino, et al.. (2005). Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri. Microbiology. 151(3). 951–962. 101 indexed citations

15.

Mavris, Maria & Philippe Sansonetti. (2004). Epithelial cell responses. Best Practice & Research Clinical Gastroenterology. 18(2). 373–386. 13 indexed citations

16.

Mavris, Maria, et al.. (2002). Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus. Molecular Microbiology. 43(6). 1543–1553. 133 indexed citations

17.

Mavris, Maria, Philippe Sansonetti, & Claude Parsot. (2002). Identification of the cis -Acting Site Involved in Activation of Promoters Regulated by Activity of the Type III Secretion Apparatus in Shigella flexneri. Journal of Bacteriology. 184(24). 6751–6759. 50 indexed citations

18.

Girardin, Stephen E., Régis Tournebize, Maria Mavris, et al.. (2001). CARD4/Nod1 mediates NF‐κB and JNK activation by invasive Shigella flexneri. EMBO Reports. 2(8). 736–742. 503 indexed citations breakdown →

19.

Mavris, Maria, Paul A. Manning, & Renato Morona. (1997). Mechanism of bacteriophage SfII‐mediated serotype conversion in Shigella flexneri. Molecular Microbiology. 26(5). 939–950. 88 indexed citations

20.

Morona, Renato, et al.. (1994). Characterization of the rfc region of Shigella flexneri. Journal of Bacteriology. 176(3). 733–747. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact